Invesco Exch Trd Slf Idx Fd
|
Q4 2021
Filed on Feb 15, 2022
|
452,791
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
15,300
|
$2.37 - $5.01
$36.3K - $76.7K
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
38,580
|
$10.83 - $14.48
$418K - $559K
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
350,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
12,365
|
$1.32 - $3.07
$16.3K - $38K
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
919,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
58,470
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
250,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
10,024
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
48,477
|
$5.45 - $6.16
$264K - $299K
|
|
Credit Suisse Nassau Branch
|
Q4 2021
Filed on Feb 15, 2022
|
165,121
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2021
Filed on Feb 15, 2022
|
185,839
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
13,078
|
N/A
|
|
Principal Exchange Traded Fd
|
Q4 2021
Filed on Feb 15, 2022
|
34,032
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
27,735
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
23,591
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
16,079
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
15,175
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
7,935
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
146,445
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
1,250,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
24,942
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
1,150,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
11,488
|
$0.5 - $0.98
$5.74K - $11.3K
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
23,368
|
N/A
|
|
Ligand Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 15, 2022
|
100,000
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
30,547
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
115,829
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
8,984
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
11,662
|
$1.32 - $3.29
$15.4K - $38.4K
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
16,832
|
N/A
|
|
First Tr Sr Floating Rate 20
|
Q4 2021
Filed on Feb 15, 2022
|
57,102
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
24,236
|
$3.93 - $5.43
$95.2K - $132K
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
21,212
|
N/A
|
|
Dragoneer Growth Oppty Corp
|
Q4 2021
Filed on Feb 15, 2022
|
85,037
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
77,510
|
N/A
|
|
Lifesci Acquisition Ii Corp
|
Q4 2021
Filed on Feb 15, 2022
|
41,158
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
13,365
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
37,839
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
14,999
|
$2.25 - $4.11
$33.7K - $61.6K
|
|
Xeris Pharmaceuticals Inc
|
Q4 2021
Filed on Feb 15, 2022
|
15,934
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
307,110
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
92,312
|
N/A
|
|
Altimar Acquisition Corp Ii
|
Q4 2021
Filed on Feb 15, 2022
|
178,196
|
N/A
|
|
Altimar Acquisition Corp Ii
|
Q4 2021
Filed on Feb 15, 2022
|
58,940
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
120,322
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
25,733
|
N/A
|
|
Athena Technology Acquisi CO
|
Q4 2021
Filed on Feb 15, 2022
|
368,117
|
N/A
|
|
Big Cypress Acquisition Corp
|
Q4 2021
Filed on Feb 15, 2022
|
35,717
|
N/A
|
|
|
Q4 2021
Filed on Feb 15, 2022
|
35,808
|
N/A
|
|